Journal of Medical Economics, Volume 7, Issue 1-4 (2004)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 7, Issue 1-4 (2004)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Volume 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Research Article

Article
Economic evaluation of MF59 adjuvanted vaccine against influenza in the high-risk elderly population in France
James Piercy MSc, James Ryan MSc & Francoise Megas MD MA
Pages: 1-18
Published online: 02 Dec 2008
AbstractforEconomic evaluation of MF59 adjuvanted vaccine against influenza in the high-risk elderly population in France | References | PDF (148.1 KB)
  • 181 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Improvement of headache symptoms and reduction in headache medication usage in patients treated with botulinum toxin type A
Peter McAllister MD
Pages: 19-28
Published online: 02 Dec 2008
AbstractforImprovement of headache symptoms and reduction in headache medication usage in patients treated with botulinum toxin type A | References | PDF (107.9 KB)
  • 83 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
A cost-utility analysis of adjunctive treatment with newer antiepileptic drugs in the UK
Edit Remák MSc, John Hutton BSc Econ B Phil, Caroline E Selai MSc DipPsych PhD, Michael R Trimble MD FRCP FRCPsych & Martin J Price PhD
Pages: 29-40
Published online: 02 Dec 2008
AbstractforA cost-utility analysis of adjunctive treatment with newer antiepileptic drugs in the UK | References | PDF (610.6 KB)
  • 185 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
The longitudinal cost of end-stage renal disease in persons with diabetes in the United States
Diane L Manninen PhD, Frederick B Dong AM MBA, Erik J Dasbach PhD, George W Carides PhD, William H Herman MPH MD & Allan J Collins MD
Pages: 41-51
Published online: 02 Dec 2008
AbstractforThe longitudinal cost of end-stage renal disease in persons with diabetes in the United States | References | PDF (256 KB)
  • 50 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Economic evaluation of extended and conventional prophylaxis with enoxaparin against venous thromboembolism in patients undergoing surgery for abdominal cancer
D Gozzard MBA, J Hutchinson MSc, A Lloyd MPhil & A Hutchings MSc
Pages: 53-65
Published online: 02 Dec 2008
AbstractforEconomic evaluation of extended and conventional prophylaxis with enoxaparin against venous thromboembolism in patients undergoing surgery for abdominal cancer | References | PDF (118.6 KB)
  • 48 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Impact on health outcome and costs of influenza treatment with oseltamivir in elderly and high-risk patients
Beate Sander RN MA MEcDev, Marlene Gyldmark MPhil, Rick Aultman MSc & Fred Y Aoki MD
Pages: 67-83
Published online: 02 Dec 2008
AbstractforImpact on health outcome and costs of influenza treatment with oseltamivir in elderly and high-risk patients | References | PDF (895.4 KB)
  • 247 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
The clinical and economic impact of pneumococcal conjugate vaccine associated herd immunity in Canada
Michael W Ford MSc, Eileen Grace PhD & Edward CY Wang PharmDMBA
Pages: 85-92
Published online: 02 Dec 2008
AbstractforThe clinical and economic impact of pneumococcal conjugate vaccine associated herd immunity in Canada | References | PDF (120.4 KB)
  • 77 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
A clinical- and cost-effectiveness comparison of venlafaxine and selective serotonin reuptake inhibitors (SSRIs) in the management of patients with major depressive disorder from the perspective of an Austrian sickness fund
P Howard MBA & C Knight BEng
Pages: 93-106
Published online: 02 Dec 2008
AbstractforA clinical- and cost-effectiveness comparison of venlafaxine and selective serotonin reuptake inhibitors (SSRIs) in the management of patients with major depressive disorder from the perspective of an Austrian sickness fund | References | PDF (177.9 KB)
  • 93 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Economic impact of recombinant activated factor VII in the control of bleeds associated with abdominal prostatectomy
IAO Odeyemi, PW Friederich & M Levi
Pages: 107-115
Published online: 02 Dec 2008
AbstractforEconomic impact of recombinant activated factor VII in the control of bleeds associated with abdominal prostatectomy | References | PDF (155.4 KB)
  • 37 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Economic modelling of antiplatelet therapy in the secondary prevention of stroke
Stephen M Beard MSc, Louise Gaffney MSc, Luke Bamber MSc & Jason De Platchett BS
Pages: 117-134
Published online: 02 Dec 2008
AbstractforEconomic modelling of antiplatelet therapy in the secondary prevention of stroke | References | PDF (141.7 KB)
  • 88 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Explore articles